Doherty Aoife, Wall Audrey, Khaldi Nora, Kussmann Martin
Nuritas Ltd., Dublin, Ireland.
Front Genet. 2021 Nov 19;12:768979. doi: 10.3389/fgene.2021.768979. eCollection 2021.
Scientific research consistently demonstrates that diseases may be delayed, treated, or even prevented and, thereby, health may be maintained with health-promoting functional food ingredients (FFIs). Consumers are increasingly demanding sound information about food, nutrition, nutrients, and their associated health benefits. Consequently, a nutrition industry is being formed around natural foods and FFIs, the economic growth of which is increasingly driven by consumer decisions. Information technology, in particular artificial intelligence (AI), is primed to vastly expand the pool of characterised and annotated FFIs available to consumers, by systematically discovering and characterising natural, efficacious, and safe bioactive ingredients (bioactives) that address specific health needs. However, FFI-producing companies are lagging in adopting AI technology for their ingredient development pipelines for several reasons, resulting in a lack of efficient means for large-scale and high-throughput molecular and functional ingredient characterisation. The arrival of the AI-led technological revolution allows for the comprehensive characterisation and understanding of the universe of FFI molecules, enabling the mining of the food and natural product space in an unprecedented manner. In turn, this expansion of bioactives dramatically increases the repertoire of FFIs available to the consumer, ultimately resulting in bioactives being specifically developed to target unmet health needs.
科学研究一直表明,疾病可能会被延缓、治疗甚至预防,因此,通过具有促进健康功能的食品成分(FFI)可以维持健康。消费者越来越需要有关食品、营养、营养素及其相关健康益处的可靠信息。因此,围绕天然食品和FFI形成了一个营养产业,其经济增长越来越受到消费者决策的推动。信息技术,特别是人工智能(AI),准备通过系统地发现和表征满足特定健康需求的天然、有效和安全的生物活性成分(生物活性物质),极大地扩大消费者可获得的已表征和注释的FFI库。然而,生产FFI的公司在将人工智能技术应用于其成分开发流程方面滞后,原因有几个,导致缺乏大规模和高通量分子及功能成分表征的有效手段。以人工智能为主导的技术革命的到来,使得对FFI分子的宇宙进行全面表征和理解成为可能,从而以前所未有的方式挖掘食品和天然产物领域。反过来,这种生物活性物质的扩展极大地增加了消费者可获得的FFI种类,最终导致专门开发针对未满足的健康需求的生物活性物质。